(Q34122414)

31 July 2017

1 reference

title

Antiarrhythmic agents: drug interactions of clinical significance (English)

1 reference

31 July 2017

T C Trujillo

1

1 reference

31 July 2017

P E Nolan

series ordinal

2

1 reference

31 July 2017

publication date

1 December 2000

1 reference

31 July 2017

1 reference

31 July 2017

volume

23

1 reference

31 July 2017

issue

6

1 reference

31 July 2017

page(s)

509-532

1 reference

Ranitidine and procainamide absorption

31 July 2017

cites work

1 reference

https://api.crossref.org/works/10.2165%2F00002018-200023060-00003

The effect of enzyme induction on the metabolism of disopyramide in man.

21 January 2018

1 reference

https://api.crossref.org/works/10.2165%2F00002018-200023060-00003

Enhanced metabolism and diminished efficacy of disopyramide by enzyme induction?

21 January 2018

1 reference

https://api.crossref.org/works/10.2165%2F00002018-200023060-00003

The impairment of lignocaine clearance by propranolol--major contribution from enzyme inhibition

21 January 2018

1 reference

https://api.crossref.org/works/10.2165%2F00002018-200023060-00003

Interrelationships of Hepatic Blood Flow, Cardiac Output, and Blood Levels of Lidocaine in Man

21 January 2018

1 reference

https://api.crossref.org/works/10.2165%2F00002018-200023060-00003

Increased toxicity and reduced clearance of lidocaine by cimetidine.

21 January 2018

1 reference

https://api.crossref.org/works/10.2165%2F00002018-200023060-00003

Reduction of oral bioavailability of lignocaine by induction of first pass metabolism in epileptic patients

21 January 2018

1 reference

https://api.crossref.org/works/10.2165%2F00002018-200023060-00003

Enhanced metabolism of mexiletine after phenytoin administration

21 January 2018

1 reference

https://api.crossref.org/works/10.2165%2F00002018-200023060-00003

Newer antidepressants and the cytochrome P450 system

21 January 2018

1 reference

https://api.crossref.org/works/10.2165%2F00002018-200023060-00003

Flecainide pharmacokinetics in healthy volunteers: the influence of urinary pH.

21 January 2018

1 reference

https://api.crossref.org/works/10.2165%2F00002018-200023060-00003

Flecainide: single and multiple oral dose kinetics, absolute bioavailability and effect of food and antacid in man.

21 January 2018

1 reference

https://api.crossref.org/works/10.2165%2F00002018-200023060-00003

Rifampicin lowers plasma concentrations of propafenone and its antiarrhythmic effect.

21 January 2018

1 reference

https://api.crossref.org/works/10.2165%2F00002018-200023060-00003

Relationship between phenytoin and tolbutamide hydroxylations in human liver microsomes

21 January 2018

1 reference

https://api.crossref.org/works/10.2165%2F00002018-200023060-00003

The Role of Combination Therapy with Mexiletine and Procainamide in Patients with Inducible Sustained Ventricular Tachycardia Refractory to Intravenous Procainamide

21 January 2018

1 reference

https://api.crossref.org/works/10.2165%2F00002018-200023060-00003

Reversal of proarrhythmic effects of flecainide acetate and encainide hydrochloride by propranolol

21 January 2018

1 reference

https://api.crossref.org/works/10.2165%2F00002018-200023060-00003

Beta-adrenoceptor blockers in atrial fibrillation: the importance of partial agonist activity

21 January 2018

1 reference

https://api.crossref.org/works/10.2165%2F00002018-200023060-00003

21 January 2018

1 reference

https://api.crossref.org/works/10.2165%2F00002018-200023060-00003

Quinidine and digoxin. An important interaction

21 January 2018

1 reference

12 December 2020

Role of combination drug therapy with a class IC antiarrhythmic agent and mexiletine for ventricular tachycardia

1 reference

12 December 2020

Efficacy of combination therapy with mexiletine and a type IA agent for inducible ventricular tachyarrhythmias secondary to coronary artery disease

1 reference

12 December 2020

Effect of fluvoxamine on the pharmacokinetics of quinidine.

1 reference

12 December 2020

The noninterference of aluminum hydroxide gel with quinidine sulfate absorption: An approach to control quinidine-induced diarrhea

1 reference

12 December 2020

Pharmacokinetic and electrophysiologic interactions of amiodarone and procainamide

1 reference

12 December 2020

Inhibition of theophylline metabolism by mexiletine in young male and female nonsmokers

1 reference

12 December 2020

Caffeine and theophylline attenuate adenosine-induced vasodilation in humans

1 reference

12 December 2020

Quinidine-enhanced beta-blockade during treatment with propafenone in extensive metabolizer human subjects

1 reference

12 December 2020

Quinidine pharmacokinetics in patients with cirrhosis or receiving propranolol

1 reference

12 December 2020

Apparent quinidine-induced digoxin toxicity after withdrawal of pentobarbital: a case of sequential drug interactions

1 reference

12 December 2020

Effect of ranitidine on procainamide disposition

1 reference

12 December 2020

Disopyramide and phenytoin interaction

1 reference

12 December 2020

ANAESTHESIA FOR ATRIAL DEFIBRILLATION: EFFECT OF QUINIDINE ON MUSCULAR RELAXATION

1 reference

12 December 2020

Effects of ofloxacin on the pharmacokinetics and pharmacodynamics of procainamide

1 reference

12 December 2020

Drug interactions with amiodarone

1 reference

12 December 2020

A comparison of antiarrhythmic-drug therapy with implantable defibrillators in patients resuscitated from near-fatal ventricular arrhythmias

1 reference

12 December 2020

Oral mexiletine-theophylline interaction

1 reference

12 December 2020

Cardiovascular effects of infused adenosine in man: potentiation by dipyridamole

1 reference

12 December 2020

Enzyme Induction: Rifampin-Disopyramide Interaction

1 reference

12 December 2020

Current treatment recommendations in antiarrhythmic therapy

1 reference

12 December 2020

Mechanism of benefit of negative inotropes in obstructive hypertrophic cardiomyopathy

1 reference

12 December 2020

The quinidine-digoxin interaction in perspective

1 reference

12 December 2020

Atenolol inhibits the elimination of disopyramide

1 reference

12 December 2020

Effectiveness of propranolol added to a type I antiarrhythmic agent for sustained ventricular tachycardia secondary to coronary artery disease

1 reference

12 December 2020

The effect of quinidine on the analgesic effect of codeine

1 reference

12 December 2020

Preoperative amiodarone as prophylaxis against atrial fibrillation after heart surgery

1 reference

12 December 2020

The effect of quinidine and other oral antiarrhythmic drugs on serum digoxin. A prospective study

1 reference

12 December 2020

The effect of coadministration of verapamil on the pharmacokinetics and metabolism of quinidine

1 reference

12 December 2020

Elucidation of the nifedipine-quinidine interaction

1 reference

12 December 2020

Combination therapy for cardiac arrhythmias

1 reference

12 December 2020

Cyclosporine-amiodarone interaction

1 reference

12 December 2020

Influence of amiodarone on genetically determined drug metabolism in humans

1 reference

12 December 2020

Nifedipine-quinidine interaction

1 reference

12 December 2020

Electrophysiologic mechanisms of antiarrhythmic efficacy of a sotalol and class Ia drug combination: elimination of reverse use dependence

1 reference

12 December 2020

Flecainide and amiodarone: combined therapy for refractory tachyarrhythmias in infancy

1 reference

12 December 2020

Steady-state interaction between amiodarone and phenytoin in normal subjects

1 reference

12 December 2020

Characteristics of the digoxin-quinidine and digoxin-verapamil interactions in the rat kidney

1 reference

12 December 2020

Interaction of Quinidine with Anticonvulsant Drugs

1 reference

12 December 2020

Beta-blocker therapy in the cardiac arrhythmia suppression trial

1 reference

12 December 2020

Contrasting effects of two xanthines, theophylline and enprofylline, on the cardio-respiratory stimulation of infused adenosine in man

1 reference

12 December 2020

Cimetidine inhibits renal procainamide clearance

1 reference

12 December 2020

Intravenous adenosine in the treatment of supraventricular tachycardia: a dose-ranging study and interaction with dipyridamole

1 reference

12 December 2020

Electrophysiologic effects and predictors of success of combination therapy with class Ia and Ib antiarrhythmic drugs for sustained ventricular arrhythmias

1 reference

12 December 2020

Effect of cimetidine on quinidine clearance

1 reference

12 December 2020

Effects of the alpha-/beta-blocking agent carvedilol on hepatic and systemic hemodynamics in patients with cirrhosis and portal hypertension

1 reference

12 December 2020

Mechanism of warfarin potentiation by amiodarone: dose--and concentration--dependent inhibition of warfarin elimination.

1 reference

12 December 2020

Medical treatment of portal hypertension

1 reference

12 December 2020

Sotalol for ventricular tachyarrhythmias: beta-blocking and class III contributions, and relative efficacy versus class I drugs after prior drug failure. ESVEM Investigators. Electrophysiologic Study Versus Electrocardiographic Monitoring

1 reference

12 December 2020

Codeine increases pain thresholds to copper vapor laser stimuli in extensive but not poor metabolizers of sparteine.

1 reference

12 December 2020

Modulation of antiarrhythmic drug effects by beta-adrenergic sympathetic stimulation

1 reference

12 December 2020

QT-interval prolongation by non-cardiac drugs: lessons to be learned from recent experience

1 reference

12 December 2020

Genetically determined adverse drug reactions involving metabolism

1 reference

12 December 2020

Hypoglycemia induced by interaction between clarithromycin and disopyramide

1 reference

12 December 2020

[Digoxin-propafenone interaction: values and limitations of plasma determination of the 2 drugs. Anti-arrhythmia effectiveness of propafenone]

1 reference

12 December 2020

Changes in the plasma levels and basic pharmacokinetic parameters of digoxin used in combination with gentamicin, amiodarone and spironolactone

1 reference

12 December 2020

Myasthenia gravis unmasked by antiarrhythmic agents

1 reference

12 December 2020

Junctional tachycardia and the role of catheter ablation

1 reference

12 December 2020

Effect of duration of lidocaine infusion and route of cimetidine administration on lidocaine pharmacokinetics.

1 reference

12 December 2020

Amiodarone increases plasma digoxin concentrations

1 reference

12 December 2020

Interaction of flecainide with digoxin and propranolol

1 reference

12 December 2020

Evidence that disopyramide does not interact with warfarin

1 reference

12 December 2020

Effects of amiodarone versus quinidine and verapamil in patients with chronic atrial fibrillation: results of a comparative study and a 2-year follow-up

1 reference

12 December 2020

Interaction between warfarin sodium and amiodarone

1 reference

12 December 2020

Amiodarone Interaction with Lidocaine

1 reference

12 December 2020

Subclassification of class I antiarrhythmic drugs: enhanced relevance after CAST

1 reference

12 December 2020

Interaction between warfarin and propafenone in healthy volunteer subjects

1 reference

12 December 2020

Effects of coadministration of propafenone on the pharmacokinetics of digoxin in healthy volunteer subjects

1 reference

12 December 2020

Genetically-determined interaction between propafenone and low dose quinidine: role of active metabolites in modulating net drug effect

1 reference

12 December 2020

Calcium antagonists. Drug interactions of clinical significance

1 reference

12 December 2020

Mortality and morbidity in patients receiving encainide, flecainide, or placebo. The Cardiac Arrhythmia Suppression Trial

1 reference

12 December 2020

The effect of a low dose of quinidine on the disposition of flecainide in healthy volunteers

1 reference

12 December 2020

Adenosine: supplementary considerations about activity and use.

1 reference

12 December 2020

Effect of rifampicin treatment on the kinetics of mexiletine

1 reference

12 December 2020

Importance of beta blockade in the therapy of serious ventricular arrhythmias

1 reference

12 December 2020

The influence of rifampin on quinidine and digoxin

1 reference

12 December 2020

Interaction between sotalol and an antacid preparation

1 reference

12 December 2020

Dofetilide, a new class III antiarrhythmic agent

1 reference

12 December 2020

Cardiovascular effects of adenosine infusion in man and their modulation by dipyridamole.

1 reference

12 December 2020

Oral dipyridamole increases plasma adenosine levels in human beings

1 reference

12 December 2020

Improved survival with an implanted defibrillator in patients with coronary disease at high risk for ventricular arrhythmia. Multicenter Automatic Defibrillator Implantation Trial Investigators

1 reference

12 December 2020

Increased procainamide plasma concentrations caused by quinidine: a new drug interaction

1 reference

12 December 2020

Theophylline toxicity after propafenone treatment: evidence for drug interaction

1 reference

12 December 2020

Mexiletine effects on theophylline disposition.

1 reference

12 December 2020

Trimethoprim alters the disposition of procainamide and N-acetylprocainamide

1 reference

12 December 2020

Kinetic evaluation of the propranolol-quinidine combination

1 reference

12 December 2020

Interaction between disopyramide and practolol

1 reference

12 December 2020

Enhanced antiarrhythmic efficacy of propafenone when used in combination with procainamide or quinidine.

1 reference

12 December 2020

Electrophysiologic effects and clinical efficacy of mexiletine used alone or in combination with class IA agents for refractory recurrent ventricular tachycardias or ventricular fibrillation

1 reference

12 December 2020

Mexiletine in the treatment of resistant ventricular arrhythmias: enhancement of efficacy and reduction of dose-related side effects by combination with quinidine

1 reference

12 December 2020

Rifampicin induction of lidocaine metabolism in cultured human hepatocytes

1 reference

12 December 2020

Mexiletine-theophylline interaction

1 reference

12 December 2020

Possible pharmacokinetic interaction with quinidine: ciprofloxacin or metronidazole?

1 reference

12 December 2020

Low dose quinidine-mexiletine combination therapy versus quinidine monotherapy for treatment of ventricular arrhythmias

1 reference

12 December 2020

Pharmacokinetic and pharmacodynamic interactions between diltiazem and quinidine.

1 reference

12 December 2020

Itraconazole increases plasma concentrations of quinidine

1 reference

12 December 2020

Ranitidine-induced changes in the renal and hepatic clearances of procainamide are correlated

1 reference

12 December 2020

Amiodarone-cyclosporine interaction in a heart transplant patient

1 reference

12 December 2020

Possible theophylline-amiodarone interaction

1 reference

12 December 2020

Quinidine-induced hypoprothrombinemic hemorrhage in patients on chronic warfarin therapy

1 reference

12 December 2020

Atrial arrhythmias after cardiothoracic surgery

1 reference

12 December 2020

Pharmacokinetic interaction between intravenous phenytoin and amiodarone in healthy volunteers

1 reference

12 December 2020

Rhythm management in atrial fibrillation--with a primary emphasis on pharmacological therapy: Part 1.

1 reference

12 December 2020

Single-dose quinidine treatment inhibits mexiletine oxidation in extensive metabolizers of debrisoquine

1 reference

12 December 2020

Lidocaine modifies the effect of succinylcholine on muscle oxygen consumption in dogs.

1 reference

12 December 2020

Quinidine inhibits the 2-hydroxylation of imipramine and desipramine but not the demethylation of imipramine

1 reference

12 December 2020

Proarrhythmia related to a kinetic and dynamic interaction of mexiletine and theophylline

1 reference

12 December 2020

Quinidine-Rifampin Interaction

1 reference

12 December 2020

Interaction of steady-state procainamide with H2-receptor antagonists cimetidine and ranitidine

1 reference

12 December 2020

Caffeine and theophylline as adenosine receptor antagonists in humans

1 reference

12 December 2020

Selecting an antiarrhythmic agent for atrial fibrillation should be a patient-specific, data-driven decision

1 reference

12 December 2020

Quinidine interaction with anticonvulsants

1 reference

12 December 2020

Possible quinidine-induced hemorrhage in a patient on warfarin sodium

1 reference

12 December 2020

Pharmacokinetic drug interactions with amiodarone

1 reference

12 December 2020

Potentially fatal interaction between erythromycin and disopyramide

1 reference

12 December 2020

Efficacy and Safety of Combination Therapy with Amiodarone and Type I Agents for Treatment of Inducible Ventricular Tachycardia

1 reference

12 December 2020

Interaction between propranolol and propafenone in healthy volunteers

1 reference

12 December 2020

[Another type of interaction between blood levels of digitalis and anti-arrhythmic drugs: digoxin and amiodarone. Experience with long-term therapy]

1 reference

12 December 2020

QT prolongation and development of torsades de pointes with the concomitant administration of oral erythromycin base and quinidine.

1 reference

12 December 2020

Disopyramide-pyridostigmine: report of a beneficial drug interaction

1 reference

12 December 2020

Effect of amiodarone on serum quinidine and procainamide levels

1 reference

12 December 2020

Ciclosporin-propafenone interaction

1 reference

12 December 2020

Inhibition of desipramine 2-hydroxylation by quinidine and quinine

1 reference

12 December 2020

Effect of oral combination therapy with mexiletine and quinidine on left and right ventricular function

1 reference

12 December 2020

Amiodarone: the expanding antiarrhythmic role and how to follow a patient on chronic therapy

1 reference

12 December 2020

General anesthesia in a child with urticaria pigmentosa

1 reference

12 December 2020

Cimetidine--quinidine interaction

1 reference

12 December 2020

Consequences of rifampicin treatment on propafenone disposition in extensive and poor metabolizers of CYP2D6

1 reference

12 December 2020

Oral digoxin pharmacokinetics during multiple-dose flecainide treatment

1 reference

12 December 2020

Recent Advances: the Cytochrome P450 Enzymes

1 reference

12 December 2020

The effect of oral cimetidine on total and unbound serum lidocaine concentrations in patients with suspected myocardial infarction.

1 reference

12 December 2020

Amiodarone-cyclosporine interaction in cardiac transplantation

1 reference

12 December 2020

Single-dose quinidine treatment inhibits metoprolol oxidation in extensive metabolizers

1 reference

12 December 2020

Comparison of the effects of cimetidine and ranitidine on the pharmacokinetics of disopyramide in man

1 reference

12 December 2020

Management of patients with atrial fibrillation. A Statement for Healthcare Professionals. From the Subcommittee on Electrocardiography and Electrophysiology, American Heart Association

1 reference

12 December 2020

Quinidine Excretion in Aciduria and Alkaluria

1 reference

12 December 2020

Transient increase in plasma quinidine concentrations during ketoconazole-quinidine therapy

1 reference

12 December 2020

Possible inhibition of hepatic metabolism of quinidine by erythromycin

1 reference

12 December 2020

Nifedipine-induced alterations in serum quinidine concentrations

1 reference

12 December 2020

The Sicilian gambit. A new approach to the classification of antiarrhythmic drugs based on their actions on arrhythmogenic mechanisms. Task Force of the Working Group on Arrhythmias of the European Society of Cardiology

1 reference

12 December 2020

Amiodarone-digoxin interaction. Clinical and experimental observations

1 reference

12 December 2020

Quinidine interaction with nifedipine and felodipine: pharmacokinetic and pharmacodynamic evaluation

1 reference

12 December 2020

Increased quinidine plasma concentrations during administration of verapamil: a new quinidine-verapamil interaction

1 reference

12 December 2020

Intolerance and ineffectiveness of mexiletine in patients with serious ventricular arrhythmias

1 reference

12 December 2020

Effects of verapamil, propranolol, and procainamide on adenosine-induced negative dromotropism in human beings

1 reference

12 December 2020

Disopyramide pharmacokinetics and metabolism: effect of inducers

1 reference

12 December 2020

Adjuvant metoprolol improves efficacy of class I antiarrhythmic drugs in patients with inducible sustained monomorphic ventricular tachycardia

1 reference

12 December 2020

Identification of drug interactions by meta-analysis of premarketing trials: the effect of smoking on the pharmacokinetics and dosage requirements for flecainide acetate

1 reference

12 December 2020

Procainamide-cimetidine drug interaction in elderly male patients

1 reference

12 December 2020

Lidocaine elimination: effects of metoprolol and of propranolol.

1 reference

12 December 2020

A prospective comparison of class IA, B, and C antiarrhythmic agents in combination with amiodarone in patients with inducible, sustained ventricular tachycardia

1 reference

12 December 2020

Human cytochrome P450 enzymes: a status report summarizing their reactions, substrates, inducers, and inhibitors

1 reference

12 December 2020

Phenytoin-quinidine interactions in a patient with recurrent ventricular tachyarrhythmias.

1 reference

12 December 2020

Quinidine-rifampin interaction

1 reference

12 December 2020

Influence of mexiletine on the pharmacokinetics of theophylline in healthy volunteers

1 reference

12 December 2020

Effect of phenytoin on the clinical pharmacokinetics of amiodarone.

1 reference

12 December 2020

An electrophysiologic study of the digoxin--quinidine interaction

1 reference

12 December 2020

Quinidine reduces clearance of (+)-propranolol more than (-)-propranolol through marked reduction in 4-hydroxylation

1 reference

12 December 2020

Dextromethorphan: enhancing its systemic availability by way of low-dose quinidine-mediated inhibition of cytochrome P4502D6.

1 reference

12 December 2020

Sotalol and type IA drugs in combination prevent recurrence of sustained ventricular tachycardia

1 reference

12 December 2020

The influence of urinary pH on flecainide excretion and its serum pharmacokinetics

1 reference

12 December 2020

Anesthetic management of the parturient receiving amiodarone.

1 reference

12 December 2020

Variable disposition kinetics and electrocardiographic effects of flecainide during repeated dosing in humans: contribution of genetic factors, dose-dependent clearance, and interaction with amiodarone

1 reference

12 December 2020

The mechanism of the interaction between amiodarone and warfarin in humans

1 reference

12 December 2020

Antiarrhythmic drugs and devices for the management of ventricular tachyarrhythmia in ischemic heart disease

1 reference

12 December 2020

Xamoterol improves the control of chronic atrial fibrillation in elderly patients

1 reference

12 December 2020

Hypotension after quinidine plus verapamil. Possible additive competition at alpha-adrenergic receptors

1 reference

12 December 2020

Effect of cimetidine on the pharmacokinetics and pharmacodynamics of quinidine

1 reference

12 December 2020

Sinus arrest and hypotension with combined amiodarone-diltiazem therapy

1 reference

12 December 2020

Ibutilide: a new class III antiarrhythmic agent.

1 reference

12 December 2020

Interaction of amiodarone with racemic warfarin and its separated enantiomorphs in humans

1 reference

12 December 2020

Altered pharmacokinetics of oral flecainide by cimetidine.

1 reference

12 December 2020

Metoprolol or Propranolol Does Not Alter the Kinetics of Procainamide

1 reference

12 December 2020

Lack of effect of cimetidine on the metabolism of quinidine: effect on renal clearance

1 reference

12 December 2020

Usefulness of oral quinidine-mexiletine combination therapy for sustained ventricular tachyarrhythmias as assessed by programmed electrical stimulation when quinidine monotherapy has failed

1 reference

12 December 2020

Trimethoprim inhibition of the renal clearance of procainamide and N-acetylprocainamide

1 reference

12 December 2020

Mechanism of interaction between theophylline and mexiletine.

1 reference

12 December 2020

Interaction between Theophylline and Mexiletine

1 reference

12 December 2020

The amiodarone--class I agent combination increases refractoriness, conduction, and the number of electrophysiologic studies. But does it increase survival rate?

1 reference

12 December 2020

The incidence, magnitude, and time course of the amiodarone-warfarin interaction

1 reference

12 December 2020

Randomised placebo-controlled trial comparing oxprenolol with disopyramide phosphate in immediate treatment of suspected myocardial infarction

1 reference

12 December 2020

Comparison of class Ia/Ib versus class III antiarrhythmic drugs for the suppression of inducible sustained ventricular tachycardia associated with coronary artery disease

1 reference

12 December 2020

Pharmacokinetic evaluation of the digoxin-amiodarone interaction

1 reference

12 December 2020

Propafenone-mexiletine combination for the treatment of sustained ventricular tachycardia

1 reference

12 December 2020

Amiodarone-digoxin interaction: clinical significance, time course of development, potential pharmacokinetic mechanisms and therapeutic implications

1 reference

12 December 2020

A Classification of Antiarrhythmic Actions Reassessed After a Decade of New Drugs

1 reference

12 December 2020

Update: clinically significant cytochrome P-450 drug interactions

1 reference

12 December 2020

beta-blockers. Drug interactions of clinical significance

1 reference

12 December 2020

Anaesthesia and amiodarone.

1 reference

12 December 2020

1 reference

12 December 2020

Effect of cimetidine on the pharmacokinetics of quinidine and lidocaine in the rat.

1 reference

12 December 2020

Propafenone-theophylline interaction

1 reference

12 December 2020

Reduction in lidocaine clearance during continuous infusion and by coadministration of propranolol.

1 reference

12 December 2020

Cardiac glycosides. Drug interactions of clinical significance

1 reference

12 December 2020

Amiodarone-induced sinus arrest successfully treated with ephedrine and isoproterenol

1 reference

12 December 2020

Concurrent use of quinidine and disopyramide: evaluation of serum concentrations and electrocardiographic effects

1 reference

12 December 2020

Differential effects of quinidine on the disposition of nifedipine, sparteine, and mephenytoin in humans

1 reference

12 December 2020

Altered Hepatic Blood Flow and Drug Disposition1

1 reference

12 December 2020

Evaluation of the Pharmacokinetic and Pharmacodynamic Interaction Between Quinidine and Nifedipine

1 reference

12 December 2020

Inhibition of the intestinal digoxin absorption and exsorption by quinidine

1 reference

12 December 2020

Altered absorption of digoxin, sustained-release quinidine, and warfarin with sucralfate administration

1 reference

12 December 2020

The effect of flecainide acetate, a new antiarrhythmic, on plasma digoxin levels

1 reference

12 December 2020

Combination of disopyramide and mexiletine for better tolerance and additive effects for treatment of ventricular arrhythmias

1 reference

12 December 2020

Dangerous interaction between amiodarone and quinidine

1 reference

12 December 2020

Effect of aluminum hydroxide gel on quinidine gluconate absorption

1 reference

12 December 2020

Quinidine-nifedipine interaction.

1 reference

12 December 2020

Effect of amiodarone on the pharmacokinetics of phenytoin, quinidine, and lidocaine in the rat.

1 reference

12 December 2020

10.2165/00002018-200023060-00003

Identifiers

DOI

1 reference

Dimensions Publication ID

31 July 2017

1040300299

0 references

1 reference